We are live on ! Find out more
CIP

Convergence Investment Partners Portfolio holdings

AUM $611M
1-Year Est. Return 61.48%
This Fund
S&P 500
This Quarter Est. Return
-4.2%
1 Year Est. Return
+61.48%
3 Year Est. Return
+199.5%
5 Year Est. Return
+275.62%
10 Year Est. Return
+998.75%
AUM
$153M
AUM Growth
-$12.1M
Cap. Flow
-$1.82M
Cap. Flow %
-1.19%
Top 10 Hldgs %
21.35%
Holding
258
New
56
Increased
66
Reduced
77
Closed
59

Top Buys

Rank Stock Value
1
LAZ icon
Lazard
LAZ
+$1.25M
2
GILD icon
Gilead Sciences
GILD
+$1.17M
3
EIX icon
Edison International
EIX
+$1.14M
4
AMGN icon
Amgen
AMGN
+$1.12M
5
CSCO icon
Cisco
CSCO
+$963K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$2.41M
2
HPQ icon
HP
HPQ
+$1.91M
3
MPC icon
Marathon Petroleum
MPC
+$1.47M
4
DUK icon
Duke Energy
DUK
+$1.36M
5
JEF icon
Jefferies Financial Group
JEF
+$1.12M

Sector Composition

Rank Sector Weight
1 Technology 19.11%
2 Healthcare 16.75%
3 Financials 16.1%
4 Consumer Discretionary 8.77%
5 Communication Services 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.91T
$4.56M 2.98%
19,597
+177
+0.9% +$46.7K
AAPL icon
2
Apple
AAPL
$4.94T
$4.46M 2.91%
32,251
-1,579
-5% -$248K
XOM icon
3
ExxonMobil
XOM
$641B
$3.61M 2.35%
41,297
+6,303
+18% +$575K
ABBV icon
4
AbbVie
ABBV
$458B
$3.23M 2.11%
24,105
-226
-0.9% -$32.4K
AMGN icon
5
Amgen
AMGN
$204B
$3.23M 2.11%
14,308
+4,622
+48% +$1.12M
GILD icon
6
Gilead Sciences
GILD
$163B
$3.09M 2.02%
50,086
+18,540
+59% +$1.17M
IBM icon
7
IBM
IBM
$204B
$2.76M 1.8%
23,249
+2,243
+11% +$294K
HD icon
8
Home Depot
HD
$337B
$2.65M 1.73%
9,606
+1,218
+15% +$360K
AMZN icon
9
Amazon
AMZN
$2.49T
$2.58M 1.69%
22,844
+3,845
+20% +$486K
CVX icon
10
Chevron
CVX
$382B
$2.52M 1.64%
17,536
-116
-0.7% -$17.7K
AVGO icon
11
Broadcom
AVGO
$1.8T
$2.52M 1.64%
56,650
+4,020
+8% +$205K
MRK icon
12
Merck
MRK
$325B
$2.48M 1.62%
28,757
+4,785
+20% +$427K
VZ icon
13
Verizon
VZ
$198B
$2.41M 1.57%
63,502
-3,908
-6% -$174K
CAH icon
14
Cardinal Health
CAH
$53.8B
$2.29M 1.49%
34,331
-847
-2% -$53.7K
WMT icon
15
Walmart Inc
WMT
$888B
$2.25M 1.47%
52,134
-2,364
-4% -$104K
CSCO icon
16
Cisco
CSCO
$448B
$2.24M 1.46%
56,072
+21,703
+63% +$963K
JPM icon
17
JPMorgan Chase
JPM
$938B
$2.1M 1.37%
20,107
-46
-0.2% -$5.28K
CVS icon
18
CVS Health
CVS
$136B
$2.04M 1.33%
21,372
-5,144
-19% -$509K
GOOG icon
19
Alphabet (Google) Class C
GOOG
$3.99T
$2.02M 1.32%
21,050
+1,790
+9% +$200K
GOOGL icon
20
Alphabet (Google) Class A
GOOGL
$4T
$1.89M 1.24%
19,790
+1,070
+6% +$119K
KMB icon
21
Kimberly-Clark
KMB
$36.9B
$1.78M 1.16%
15,803
-899
-5% -$117K
LMT icon
22
Lockheed Martin
LMT
$134B
$1.75M 1.14%
4,521
+34
+0.8% +$14.2K
BNY
23
Bank of New York Mellon
BNY
$107B
$1.64M 1.07%
42,619
+18,986
+80% +$809K
PM icon
24
Philip Morris
PM
$305B
$1.64M 1.07%
19,773
+5,279
+36% +$503K
MS icon
25
Morgan Stanley
MS
$334B
$1.63M 1.06%
20,570
-87
-0.4% -$7.33K
1
2 3 4 5

Similar funds

FFWA
FRG Family Wealth Advisors Bellevue, Washington $611M AUM 25.92% 1-Year Est. Return
VV
Verbena Value Westport, Connecticut $611M AUM
CBB
Citizens Business Bank Ontario, California $610M AUM 27.86% 1-Year Est. Return
1SAMC
12th Street Asset Management Company Nashville, Tennessee $611M AUM 27.12% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
PL
Pandi LLC Leawood, Kansas $610M AUM 14.97% 1-Year Est. Return
BFC
Blue Fin Capital Warren, Rhode Island $610M AUM 26.46% 1-Year Est. Return
DCM
DGS Capital Management Jersey City, New Jersey $609M AUM 44.78% 1-Year Est. Return

Convergence Investment Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Convergence Investment Partners held 258 positions worth $153M, down 7.3% from $165M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Convergence Investment Partners's Q3 2022 filing shows 56 new, 66 increased, 77 reduced and 59 closed positions. Its largest new stake was Lazard: 34,896 shares worth $1.11M. The largest sale was Pfizer, an estimated $2.41M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

  • Convergence Investment Partners's largest Q3 2022 buy was Lazard: 34,896 shares worth $1.11M.
  • Convergence Investment Partners added most to Gilead Sciences in Q3 2022, an estimated $1.17M increase.
  • Convergence Investment Partners's biggest Q3 2022 reduction was Pfizer, cutting an estimated $2.41M.
  • Convergence Investment Partners fully exited HP in Q3 2022, selling an estimated $1.91M.
  • Convergence Investment Partners's ten largest holdings make up 21% of its $153M portfolio in Q3 2022.
  • Convergence Investment Partners opened 56 new positions and closed 59 in Q3 2022.
  • Convergence Investment Partners's portfolio value fell 7.3% quarter-over-quarter to $153M.

Based on Convergence Investment Partners's 13F filing for Q3 2022, filed 8 Nov 2022.